Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 2,514,559 |
|
|||||
| News | - | ||||||
| Day High | 14.52 | Low High |
|||||
| Day Low | 13.45 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sage Therapeutics Inc | SAGE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.05 | 8.11% | 14.00 | 19:32:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 13.85 | 13.45 | 14.52 | 14.00 | 12.95 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 24,592 | 2,514,559 | $ 14.08 | $ 35,398,958 | - | 10.92 - 59.99 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:33 | 7 | $ 14.31 | USD |
Sage Therapeutics (SAGE) Options Flow Summary
Sage Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 842.7M | 60.11M | - | 86.46M | -541.49M | -9.01 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sage Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAGE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.96 | 14.52 | 10.92 | 12.83 | 1,789,575 | 1.04 | 8.02% |
| 1 Month | 18.80 | 19.34 | 10.92 | 15.02 | 1,109,598 | -4.80 | -25.53% |
| 3 Months | 25.87 | 27.39 | 10.92 | 19.79 | 1,019,986 | -11.87 | -45.88% |
| 6 Months | 18.50 | 28.26 | 10.92 | 20.76 | 948,785 | -4.50 | -24.32% |
| 1 Year | 47.59 | 59.99 | 10.92 | 25.74 | 1,088,948 | -33.59 | -70.58% |
| 3 Years | 77.42 | 80.87 | 10.92 | 34.83 | 767,911 | -63.42 | -81.92% |
| 5 Years | 167.93 | 193.56 | 10.92 | 50.05 | 751,387 | -153.93 | -91.66% |
Sage Therapeutics Description
| Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development. |
